What is Arcutis Biotherapeutics, Inc.'s total revenue?

Arcutis Biotherapeutics, Inc. (ARQT) reported total revenue of $105.4M in Q1 2026.

How has Arcutis Biotherapeutics, Inc.'s total revenue changed year-over-year?

Arcutis Biotherapeutics, Inc.'s total revenue increased by 60.1% year-over-year, from $65.85M to $105.4M.

What is the long-term trend for Arcutis Biotherapeutics, Inc.'s total revenue?

Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s total revenue has grown at a 367.3% compound annual growth rate (CAGR), from $3.69M to $376.07M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Arcutis Biotherapeutics, Inc. ARQT Total Revenue

Total Revenue at other companies

PfizerPFE

$14.45B+5.4%

AmgenAMGN

$8.62B+5.8%

IncyteINCY

$1.27B+20.9%

OrganonOGN

$1.46B-3.5%

Kymera TherapeuticsKYMR

$34.37M+55.5%

Kiniksa Pharmaceuticals International, plcKNSA

$214.27M+55.5%

Segments

By product

See full

ZORYVE Cream0.3$30.76M—

ZORYVE Cream0.15$7.47M—

ZORYVE Cream0.05$0—

By segment

See full

Reportable Segment$105.4M+60.1%

Other financials

Income statement

See full

Gross profit$95.6M+67.7%

Operating income-$9.1M+62.9%

Net income-$11.3M+54.9%

EPS (diluted)-$0.09+55.0%

Balance sheet

See full

Cash & equivalents$35.1M-34.7%

Total debt$114.7M+3.5%

Total equity$189.6M+32.9%

Total assets$460.0M+33.7%

Cash flow

See full

Operating cash flow$2.2M+107%

CapEx--100%

Free cash flow$2.2M+107%

Valuation

See full

Market cap$3.28B+57.5%

Enterprise value$3.36B+57.0%

P/S7.9×-1.9×

Profitability

See full

Gross margin90.9%+2.5pp

Operating margin-12%-5.7pp

Net margin-13.9%-6.6pp

FCF margin-52.5%-21.9pp

Returns & leverage

See full

Return on equity-28.2%-13.0pp

Debt / equity0.6×-0.2×

Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s total revenue?: Arcutis Biotherapeutics, Inc. (ARQT) reported total revenue of $105.4M in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s total revenue changed year-over-year?: Arcutis Biotherapeutics, Inc.'s total revenue increased by 60.1% year-over-year, from $65.85M to $105.4M.
What is the long-term trend for Arcutis Biotherapeutics, Inc.'s total revenue?: Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s total revenue has grown at a 367.3% compound annual growth rate (CAGR), from $3.69M to $376.07M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.